US 7282206
Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
granted A61KA61K38/00A61P
Quick answer
US patent 7282206 (Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Oct 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K38/00, A61P, A61P1/00, A61P1/16